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A B S T R A C T
Objective. To determine if lower starting pulse ﬂuoroscopy rates lead to lower overall radiation exposure without
increasing complication rates or perceived procedure length or difﬁculty.
Setting. The pediatric cardiac catheterization laboratory at University of Michigan Mott Children’s Hospital.
Patients. Pediatric patients with congenital heart disease.
Design/Interventions. We performed a single-center quality improvement study where the baseline pulse ﬂuoros-
copy rate was varied between cases during pediatric cardiac catheterization procedures.
Outcome Measures. Indirect and direct radiation exposure data were collected, and the perceived impact of the
ﬂuoroscopy rate and procedural complications was recorded. These outcomes were then compared among the
different set pulse ﬂuoroscopy rates.
Results. Comparing pulse ﬂuoroscopy rates of 15, 7.5, and 5 frames per second from 61 cases, there was a signiﬁcant
reduction in radiation exposure between 15 and 7.5 frames per second. There was no difference in perceived case
difﬁculty, procedural length, or procedural complications regardless of starting pulse ﬂuoroscopy rate.
Conclusions. For pediatric cardiac catheterizations, a starting pulse ﬂuoroscopy rate of 7.5 frames per second
exposes physicians and their patients to signiﬁcantly less radiation with no impact on procedural difﬁculty or
outcomes. This quality improvement study has resulted in a signiﬁcant practice change in our pediatric cardiac
catheterization laboratory, and 7.5 frames per second is now the default ﬂuoroscopy rate.
Key Words. Congenital Heart Disease; Pediatric Diagnostic Catheterization; Patient-Centered Outcomes
Research; Radiation Physics; Dosimetry
Introduction
Cardiac catheterizations constitute a majorsource of radiation exposure for patients with
congenital heart disease, particularly those patients
requiring repeated procedures for either diagnos-
tic, interventional, or biopsy-related reasons. As
children are up to 10 times more sensitive to the
stochastic effects of ionizing radiation and have a
longer life expectancy compared to adults, there is
potential for repeated exposure and manifestation
of the ill effects of radiation exposure.1 Thus,
efforts to reduce radiation dose are an important
aspect of improving patient safety during pediatric
cardiac catheterization procedures.
One potential way to lower radiation exposure
is to lower pulse ﬂuoroscopy rate (PFR). Histori-
cally, changing from conventional “continuous”
(interlaced) ﬂuoroscopy to pulsed ﬂuoroscopy
resulted in a 42% exposure reduction and thereby
revealed the importance of balancing quality of
imaging with amount of radiation exposure.2 In
the adult population, lower PFR has been shown
to further reduce radiation dose to patients.3
However, because of their higher heart rates, low-
ering PFR in children could result in longer ﬂuo-
roscopy times due to poor visualization of cardiac
structures.
The purpose of this study was to evaluate the
effect of lower PFR on radiation exposure and
image quality in a pediatric cardiac catheterization
laboratory in an effort to initiate change in physi-
cian radiation practice patterns. We hypothesized
that lower starting PFR would result in lower
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radiation exposure without compromising the
ability to complete the cardiac catheterization,
lengthening the procedure, or causing procedural
complications.
Materials and Methods
Between March 2013 and May 2013, all diagnos-
tic and interventional catheterizations performed
in the pediatric cardiac catheterization laboratory
at the University of Michigan Congenital Heart
Center by three primary interventional cardiol-
ogy attendings were included in the study. Cases
involving only placement of central venous cath-
eters were excluded. Prior to each case, the base-
line PFR was selected randomly within each
physician’s preexisting “standard” and “low-dose”
practice patterns. Because of variation in each
individual physician’s typical radiation practice
patterns, the “standard” PFR was either 15 or 7.5
frames per second (fps), and the “low” PFR
was either 7.5 or 5 fps, thus creating 3 patient
groups: 15 fps, 7.5 fps, and 5 fps. Physicians were
encouraged to change the PFR during the pro-
cedure as they felt necessary for appropriate
patient care.
Tomonitor radiation exposure, patient dose was
indirectly recorded using standard techniques,
including total ﬂuoroscopy time (minutes), air
kerma (mGy), and dose area product (μGy·m2).
Additionally, physician radiation exposure was
directly measured (mrem) using Instadose dosim-
etry badges (Mirion Technologies, Inc., Smyrna,
GA, USA), which were placed on the outside
collar of the standard lead apron for every physi-
cian in the procedure (attending interventionalists
and pediatric cardiology fellows). After each case,
these badges were analyzed for the highest indi-
vidual dosimeter dose, and the average of the two
highest dosimeter dosages was recorded without
physician knowledge of the result. Due to similari-
ties between these numbers, only the averages of
the two highest dosimeter dosages are presented in
this paper.
At the completion of the case, the attending
physician was asked to ﬁll out a survey to assess
various case factors, including degree of case dif-
ﬁculty as well as the impact of the set PFR on the
case difﬁculty and outcome of the procedure. Case
complexity was assessed using an aggregate com-
plexity score (maximum difﬁculty = 12), which was
composed of individual complexity scores for vas-
cular access (maximum difﬁculty = 4), the diagnos-
tic portion of the procedure (maximum difﬁculty =
4), and the interventional portion of the procedure
(maximum difﬁculty = 4). The maximum possible
case complexity score for diagnostic cases was
therefore 8, and for interventional cases it was 12.
Additionally, the number of angiograms per-
formed, changes in ﬂuoroscopy rate carried out by
the user, and the use of lead shielding were
recorded by the study team at the conclusion of
each case.
Group comparisons between starting PFR
groups were made in patient and procedural char-
acteristics using chi-square test or Fisher’s exact
test for categorical variables and Wilcoxon rank-
sum test for continuous variables. Similar com-
parisons were also made between providers in the
7.5-fps group to examine the impact of practice
variability. The independent association of start-
ing PFR with radiation exposure was determined
using multivariable logistic regression controlling
for case type and number of angiograms. In the
logistic regression, radiation exposure was evalu-
ated as a binary outcome using the 25th percentile
or median value. The adjusted odds ratio and 95%
conﬁdence interval obtained from logistic regres-
sion were reported. Lastly, a correlation between
direct and indirect methods of measuring radia-
tion exposure was evaluated using the Spearman
correlation coefﬁcient. Analysis was based on the
intent-to-treat principle. All statistical analysis was
performed using SAS version 9.3 (SAS Institute
Inc, Cary, NC, USA). P values less than .05 were
considered statistically signiﬁcant.
This study was approved with exempt status by
our institutional review board.
Results
Over the study period, 61 procedures were
included in the analysis (starting PFRs of 15 fps
[n = 20], 7.5 fps [n = 25], and 5 fps [n = 16]). There
were no differences in baseline demographics and
case complexity between PFR groups. There was,
however, a signiﬁcant difference in case type
between groups, with more diagnostic cases in the
15-fps group and more interventional cases in the
7.5-fps group (Table 1).
A starting PFR of 7.5 fps was associated with a
signiﬁcant reduction in radiation exposure com-
pared to 15 fps (Table 1), which remained signiﬁ-
cant after controlling for case type and number of
angiograms performed (Table 2). There was no
difference in radiation exposure between 7.5 and
5 fps.
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There were no signiﬁcant differences in
physician-perceived ability to complete the proce-
dure or impact of PFR on the procedural length
between any of the PFR groups (Table 3). There
were no complications observed during the study
and therefore no complications attributable to
PFR.
In order to determine interphysician variability
within the 7.5-fps group, we compared providers
and found both patient characteristics and case
type/complexity to be similar. Despite the use of
more radiation-blocking techniques for one phy-
sician, there were no signiﬁcant differences in
radiation exposure between providers (Table 4).
Comparing the indirect and direct methods of
measuring radiation exposure, a positive correla-
tion was found between all the indirect measures
of patient radiation exposure and the direct mea-
surement of physician radiation exposure using the
case-speciﬁc dosimetry badges (Table 5).
Table 1. Comparison of Patient and Clinical Characteristics between Initial Pulse Fluoroscopy Rate Groups (n = 61)
Characteristics
Initial fluoroscopy rate (fps) P value
5 (n = 16) 7.5 (n = 25) 15 (n = 20) 5 vs. 7.5 7.5 vs. 15
Age at procedure (years), median (IQR) 4.5 (1.8–13.7) 2.7 (0.5–7.7) 3.8 (1.3–16.6) .19 .10
Weight (kg), median (IQR) 13.9 (10.9–45.2) 12.1 (6.3–23.2) 15.6 (10.3–55.0) .16 .14
Body surface area (m2), median (IQR) 0.61 (0.49–1.4) 0.53 (0.31–0.95) 0.67 (0.46–1.54) .23 .17
Case type, n (%)*
Diagnostic 8 (50.0) 9 (36.0) 14 (70.0) .33 .01
Intervention 7 (43.8) 15 (60.0) 4 (20.0)
Biopsy 1 (6.3) 1 (4.0) 2 (10.0)
Case complexity score, median (IQR)
Diagnostic procedures 4 (2.5–4.5) 3.5 (2.5–4.5) 4 (3–5) .79 .26
Interventional procedures 6 (5–7) 5 (5–7) 5.5 (3.5–7.5) .64 .80
Radiation exposure (mrem), average of
two highest dosimeter readings (IQR)
2.3 (0–5.8) 2 (0–4) 4.3 (2.3–11.5) .54 .0496
*Comparison made only between diagnostic and interventional case types, given low number of biopsy cases.
IQR, interquartile range.
Table 2. Association between Radiation Exposure and Initial Pulse Fluoroscopy Rate Controlling for Number of Angio-
grams and Case Type (n = 61)
Initial fluoroscopy rate (fps)
Radiation exposure (mrem)*
>0 (25th percentile) ≥3 (median)
AOR (95% CI) P AOR (95% CI) P
7.5 vs. 5 0.59 (0.12–3.03) .53 1.07 (0.22–5.17) .93
15 vs. 7.5 7.52 (1.15–49.0) .03 7.00 (1.29–37.9) .02
Patients undergoing biopsy were not included in the model due to small sample size.
*Average of two highest physician dosimeters.
AOR, adjusted odds ratio; CI, confidence interval.
Table 3. Perceived Impact of Initial Pulse Fluoroscopy Rate on Procedural Difficulty and Procedure Length (n = 61)
Responses to questions, n (%)
Initial fluoroscopy rate (fps) P value*
5 (n = 16) 7.5 (n = 25) 15 (n = 20) 5 vs. 7.5 7.5 vs. 15
“Did the starting fluoroscopy rate impede your ability to complete the
procedure as planned?”
Definitely not 15 (93.8) 23 (92.0) 20 (100.0) 1.00 1.00
Probably not 0 (0.0) 1 (4.0) 0 (0.0)
Possibly 0 (0.0) 0 (0.0) 0 (0.0)
Definitely 1 (6.3) 1 (4.0) 0 (0.0)
“Did the starting fluoroscopy rate increase the length of the procedure?”
Definitely not 15 (93.8) 22 (88.0) 17 (85.0) 1.00 1.00
Probably not 0 (0.0) 1 (4.0) 1 (5.0)
Possibly 0 (0.0) 1 (4.0) 0 (0.0)
Definitely 1 (6.3) 0 (0.0) 0 (0.0)
Unknown 0 (0.0) 1 (4.0) 2 (10.0)
*Comparisons of difficulty/length were made as definitely not/probably not vs. possibly/definitely.
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Discussion
Similarly to what has been reported in the adult
cardiac catheterization literature, this quality
improvement study showed that lowering the PFR
from 15 to 7.5 fps was associated with a signiﬁcant
decrease in measured direct radiation exposure.
While our study focused on PFR, a signiﬁcant
amount of radiation exposure during cardiac cath-
eterizations occurs during cineangiography due to
higher frame rates and higher energy and radia-
tion doses, as well as due to longer procedural
duration during interventional cases. Yet we found
that the radiation reduction at 7.5 fps remained
signiﬁcant after controlling for the number of
angiograms and the case type, further emphasizing
the importance of lowering the PFR to minimize
radiation exposure. Equally importantly, lower
PFR was not associated with any perceived differ-
ences in procedural difﬁculty or length, and there
were no complications related to the lower PFR.
Because many patients with congenital heart
disease undergo multiple cardiac catheterization
procedures, they are exposed to ionizing radiation,
which can have both immediate and long-term
effects. The negative consequences of ionizing
radiation can also be categorized as either deter-
ministic or stochastic effects. While deterministic
effects, like cataract formation or skin injury, have
a somewhat predictable dose–response relation-
ship, with degree of injury directly correlating
with absorbed radiation dose, stochastic effects,
like cancer and genetic mutations, are unpredict-
able without threshold effect.4 Strides have been
made, particularly in the past decade, in improving
radiation safety proﬁles as well as public aware-
ness. Initiatives such as the ALARA (as low as
reasonably achievable) conference, conducted by
the Society for Pediatric Radiology in 2006, con-
cluded that ﬂuoroscopy dose optimization and
reduction were key areas of concern.5 Campaigns
such as “Image Gently, Step Lightly,” ﬁrst
launched in August of 2009, incorporated a stan-
dard safety checklist to encourage proper prepara-
tion, technique, and strategies to lower radiation
exposure.6 In particular, this checklist encouraged
utilizing pulse ﬂuoroscopy rather than continuous
ﬂuoroscopy when possible, as well as the using the
lowest pulse rate possible.
In this study, we did not see a further reduction
in radiation exposure in the 5-fps group compared
to the 7.5-fps group. However, there were also no
differences in the impact of PFR on procedure
length or case difﬁculty between these groups.
Due to our study design and intent-to-treat analy-
sis, physicians were able to lower the set PFR
during procedures. In fact, some patients (6 of 25,
24%) in the 7.5-fps group actually received a lower
ﬂuoroscopy rate. For this reason, 5 fps may still
offer potential radiation-lowering advantages over
7.5 fps. Therefore, continuing to strive for ultra-
low radiation exposure in pediatric cardiac
Table 4. Comparison of Patient and Clinical Characteristics between Providers at the Initial Fluoroscopy Rate of 7.5 fps
(n = 25)
Characteristics Provider 1 (n = 14) Provider 2 (n = 11) P value
Age at procedure (years), median (IQR) 2.5 (0.8–11.3) 2.7 (0.01–7.7) .63
Weight (kg), median (IQR) 11.9 (7.0–36.8) 12.2 (3.7–23.2) .75
Body surface area (m2), median (IQR) 0.5 (0.4–1.2) 0.5 (0.2–1.0) .75
Case type, n (%)*
Diagnostic 6 (42.9) 3 (27.3) .42
Intervention 7 (50.0) 8 (72.7)
Biopsy 1 (7.1) 0 (0.0)
Case complexity score, median (IQR)
Diagnostic procedure 3 (3–4) 4 (2–6) .66
Interventional procedure 6 (5–7) 5 (3.5–7.5) .42
Usage of additional lead shielding, n (%) 7 (50.0) 0 (0.0) .01
Radiation exposure (mrem), average of two highest dosimeter readings (IQR) 2.8 (0–6) 0 (0–3) .15
Because of the similar practice patterns of two providers, their data were grouped together and presented as one dataset.
*Comparison was made between diagnostic and interventional case types given low number of biopsy cases group.
Table 5. Correlation between Direct and Indirect Mea-
sures of Radiation Exposure (n = 61)
Indirect measurements of total
radiation exposure†
Direct measurement of radiation
exposure (mrem)*
r P value
Minutes 0.43 .0005
mGy 0.64 <.001
mGy/BSA 0.55 <.001
mGy/min 0.49 <.001
mGy/min/BSA 0.32 .01
Dose area product‡ 0.60 .0003
*Radiation dose to physicians measured using dosimetry badges.
†Fluoroscopy equipment-derived measurement of patient radiation exposure.
‡Only measured for subset of population (32/61, 52%).
BSA, body surface area; r, Spearman correlation coefficient.
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catheterization procedures should be a benchmark
for the highest-quality care.
A limitation of our study was the potential for
interphysician practice variation (apart from start-
ing PFR) that could impact radiation exposures.
The use of lead screens and shields, as well as
awareness and incorporation of best practices for
minimizing radiation exposure, can vary from phy-
sician to physician. In an effort to examine the
impact of this practice heterogeneity, we com-
pared providers within the 7.5-fps group and
found no group difference in radiation exposures.
While this does not mean that other radiation-
lowering techniques are not important in lowering
radiation exposure, it shows that in this study
population, they had less impact on lowering
radiation doses compared with lowering the PFR.
While lowering the baseline PFR is a ﬁrst step
toward radiation reduction in pediatric cardiac
catheterization procedures, further efforts to
lower radiation exposure of both patients and phy-
sicians might include lowering the frame rate of
cineangiograms, more consistent use of radiation
barriers like lead shields, and using nonﬂuoro-
scopic imaging techniques as adjunctive tools
during catheterization procedures. Well-planned,
well-executed quality improvement studies might
provide both insight into and progress in truly
achieving the lowest achievable radiation dose for
patients.
Although not the primary focus of the study, we
found that the case-speciﬁc dosimeters were an
excellent surrogate marker for patient radiation
exposure. Thus, the use of similar dosimeters
offers a more direct way to measure radiation
exposure, and although the devices cannot
measure deep tissue exposure, the potential to
place these devices on patients and directly
measure skin exposure may improve our ability to
measure the effect of radiation-lowering efforts in
the future.
Conclusions
This quality improvement study revealed that a
starting PFR of 7.5 fps was associated with a sig-
niﬁcant reduction in radiation exposure compared
with 15 fps with no adverse effects. For this
reason, we have changed the practice of all attend-
ing interventionalists in our pediatric cardiac cath-
eterization laboratory so that the default starting
ﬂuoroscopy rate for every procedure is set to
7.5 fps.
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